Open label clinical study to evaluate the safety and efficacy of ProvayBlueTM (methylene blue) for the treatment of acquired methemoglobinemia

Trial Profile

Open label clinical study to evaluate the safety and efficacy of ProvayBlueTM (methylene blue) for the treatment of acquired methemoglobinemia

Not stated
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Methylthioninium chloride (Primary)
  • Indications Methaemoglobinaemia
  • Focus Therapeutic Use
  • Sponsors Provepharm
  • Most Recent Events

    • 22 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top